Stocks to watch at the open

The rivalry between CSL and Baxter intensifies, David Jones’ Q1 sales are out and Newcrest hits another rough patch.


Competitor to CSL, Baxter International, has submitted an application to the European Medicines Agency to approve its Haemophilia B drug.


SMS Code Sent…

Hi {{ user.FirstName }}

Looks like you've already taken a free trial

Please enter your payment details

We have sent you a code via SMS to {{user.DayPhone}}

please enter this code below to activate your membership

If you didn't receive SMS code please

Looks you are already a member. Please enter your password to proceed

Please untick this box when using a public or shared device

Verify your mobile number to unlock a FREE trial

Please sign up for full access

Updating information

Please wait ...

  • Mastercard
  • Visa

Related Articles